Nutrition Guide
Omega-3 Fatty Acids and Heart Health: What the Science Says
The EPA vs. DHA debate, the trial that changed prescribing, and what matters for your triglycerides.
Written by the ArterAI team · Last reviewed April 2026
This content is for informational purposes only and does not constitute medical advice. Always consult your physician regarding your individual health decisions.
The omega-3 story in cardiology has taken a sharp turn in the last decade, and most popular health content hasn't caught up. For years, the general advice was simple: eat fish, maybe take a fish oil supplement, your heart will benefit. Then a series of large trials in the 2010s — ASCEND, VITAL, STRENGTH — showed no meaningful cardiovascular benefit from standard-dose EPA+DHA supplementation. The “fish oil is good for your heart” narrative was looking increasingly fragile.
Then REDUCE-IT happened. And it complicated everything.
REDUCE-IT: The Trial That Changed the Conversation
The REDUCE-IT trial (2019) enrolled 8,179 patients already on statin therapy with elevated triglycerides (135-499 mg/dL) and either established cardiovascular disease or diabetes plus additional risk factors. They were randomized to receive 4g/day of icosapent ethyl (Vascepa) — a purified EPA-only formulation — or mineral oil placebo.
The result: a 25% relative risk reduction in the composite of cardiovascular death, nonfatal heart attack, nonfatal stroke, coronary revascularization, and unstable angina. Twenty-five percent — on top of statin therapy. This is a number that demands attention.
Key numbers from REDUCE-IT:
- • 25% relative risk reduction in major cardiovascular events
- • 4.8% absolute risk reduction (17.2% vs. 22.0% event rate)
- • NNT of 21 over 4.9 years — meaning you treat 21 people for about 5 years to prevent one event
- • Triglycerides dropped ~18% — but the benefit was observed across all triglyceride levels, suggesting mechanisms beyond triglyceride lowering
The caveat: REDUCE-IT used mineral oil as its placebo, and mineral oil may have increased LDL and CRP in the control group, potentially inflating the apparent benefit. This has been debated extensively. The FDA reviewed this concern and still approved icosapent ethyl for cardiovascular risk reduction, but it's a legitimate critique that you should be aware of.
EPA Alone vs. EPA+DHA: This Distinction Matters
The most important finding in recent omega-3 research isn't about dose — it's about composition. Purified EPA works. EPA+DHA combinations, at least for cardiovascular events, do not appear to.
EPA-Only (Icosapent Ethyl)
This is an uncomfortable finding for the supplement industry. The vast majority of fish oil products on shelves are EPA+DHA blends, and the large trials testing these blends have shown no cardiovascular event reduction. The positive evidence is specifically for high-dose purified EPA. That distinction gets lost in marketing copy that treats all omega-3s as interchangeable.
The Three Types and What They Actually Do
EPA (Eicosapentaenoic Acid)
The form with the strongest cardiovascular evidence. Reduces triglycerides, lowers inflammation (hsCRP drops ~20-30% at therapeutic doses), stabilizes arterial plaque, and improves endothelial function. Found in fatty fish and purified prescription supplements. At 4g/day, EPA reduces triglycerides by approximately 18-20% and has demonstrated a 25% reduction in cardiovascular events.
DHA (Docosahexaenoic Acid)
Critical for brain development and neurological function. Also found in fatty fish. DHA does reduce triglycerides, but it raises LDL by roughly 5-10% — which may partly explain why EPA+DHA blends don't show the same cardiovascular benefit as EPA alone. DHA remains important during pregnancy and for neurological health; the issue is specifically with cardiovascular event reduction.
ALA (Alpha-Linolenic Acid)
The plant-based omega-3, found in flaxseed, chia seeds, walnuts, and canola oil. Your body can convert ALA to EPA, but the conversion rate is roughly 5-8% — and conversion to DHA is even lower, under 5%. At these rates, you would need to consume approximately 25-40g of ALA daily to achieve the EPA levels tested in clinical trials, which is not practically achievable through food. ALA has modest anti-inflammatory properties on its own, but it cannot substitute for marine omega-3s for triglyceride management.
Triglyceride Reduction: The Numbers
Omega-3s reduce triglycerides by decreasing hepatic VLDL production and accelerating triglyceride clearance. The magnitude depends on dose, your starting level, and the formulation:
| Intervention | TG Reduction | Notes |
|---|---|---|
| Fish 2-3x/week | 5-10% | ~0.5g EPA+DHA per serving; benefits beyond TG reduction |
| OTC fish oil (1-2g EPA+DHA) | 10-20% | No cardiovascular event reduction demonstrated at this dose |
| Rx icosapent ethyl (4g EPA) | ~18% | 25% CVD event reduction (REDUCE-IT); EPA-only |
| Rx omega-3 acid ethyl esters (4g EPA+DHA) | 20-30% | FDA-approved for TG > 500 mg/dL; no CVD event benefit (STRENGTH) |
The higher your starting triglycerides, the larger the absolute drop. Someone starting at 400 mg/dL will see a much more dramatic reduction than someone at 180 mg/dL. For triglyceride management specifically, combining omega-3s with sugar and refined carb reduction produces the most significant results — these interventions work through different mechanisms and their effects are roughly additive.
Food vs. Supplements: A Position
For the general population without elevated triglycerides or existing CVD, we think the evidence strongly favors food over supplements. Two to three servings of fatty fish per week provides roughly 0.5-1.5g of EPA+DHA per serving alongside selenium, vitamin D, iodine, and high-quality protein. The large trials (ASCEND, VITAL) found no cardiovascular benefit from 1g/day fish oil supplements in people without established disease. Eating actual fish, by contrast, is consistently associated with reduced cardiovascular risk in cohort studies — likely because of the nutrient package, not just the omega-3 content.
Best Fish Sources (EPA+DHA per 3oz cooked serving)
- • Wild salmon: ~1.5g — the most bang per serving; Costco frozen sockeye is a cost-effective option
- • Atlantic mackerel: ~1.3g — often cheaper than salmon; buy canned for convenience
- • Sardines: ~1.0g — Wild Planet and Season Brand are good canned options; eat bones for calcium
- • Herring: ~1.0g — underrated; smoked herring on crackers is an easy snack
- • Anchovies: ~0.9g — dissolve into pasta sauce or salad dressing for umami without fishiness
- • Rainbow trout: ~0.8g — often farmed sustainably; mild flavor for people who “don't like fish”
- • Albacore tuna: ~0.7g — limit to 2-3 servings/week due to mercury; choose chunk light for lower mercury
Supplements become a different calculus for people with elevated triglycerides (above 150 mg/dL) or established cardiovascular disease. In those populations, the discussion should be about prescription-grade icosapent ethyl (4g/day), not over-the-counter fish oil. This is a conversation for your doctor, not a self-treatment decision.
If You Do Supplement: Quality Certifications Matter
The fish oil supplement market has a quality problem. Independent testing by ConsumerLab and others has found products with less EPA/DHA than labeled, significant oxidation (rancid oils), and contamination. If you're going to supplement, look for third-party certifications:
IFOS (5-Star)
International Fish Oil Standards. Tests for potency, purity (heavy metals, PCBs, dioxins), and oxidation. The most rigorous omega-3-specific certification. A 5-star rating means the product passed all categories.
USP Verified
U.S. Pharmacopeia verification. Tests that the product contains what the label claims, is not contaminated, and was manufactured under good practices. Widely recognized; fewer omega-3 products carry this than IFOS.
ConsumerLab Approved
Independent testing for label accuracy and purity. ConsumerLab publishes detailed reports comparing dozens of products side by side, including cost-per-effective-dose calculations. Requires a subscription ($39/year) but worth it if you buy supplements regularly.
A practical note: Always check that the label lists specific EPA and DHA amounts per serving — not just “total omega-3s,” which includes inactive forms. A capsule claiming “1000mg fish oil” might contain only 300mg of combined EPA+DHA. The rest is other fats. Read the supplement facts panel, not the front of the bottle.
Safety: The Atrial Fibrillation Signal
High-dose omega-3 supplementation (3g+ daily) carries a real atrial fibrillation risk. A meta-analysis of seven randomized trials (81,210 participants) found that marine omega-3 supplementation increased the risk of atrial fibrillation by 25% (HR 1.25, 95% CI 1.07-1.46). REDUCE-IT specifically found a 5.3% AF rate in the icosapent ethyl group vs. 3.9% in the placebo group.
This isn't a reason to avoid omega-3s — but it is a reason to take therapeutic doses under medical supervision rather than self-prescribing. The risk-benefit calculation for someone with established CVD and elevated triglycerides is very different from someone with normal lipids taking fish oil “just in case.”
Other Safety Considerations
- • Bleeding: Doses above 3g/day increase bleeding time. If you take warfarin, aspirin, or other anticoagulants, this interaction needs monitoring
- • Mercury (fish): Stick to lower-mercury species — salmon, sardines, trout, herring. Avoid swordfish, king mackerel, tilefish. Supplements are purified and mercury is not a concern
- • GI side effects: Fish burps, nausea, and loose stools are common at higher doses. Enteric-coated capsules or taking with meals helps. Freezing capsules before taking also reduces fishy reflux
The Bottom Line
Eat fatty fish two to three times per week. This is the single best omega-3 intervention for the general population, and it's the one recommendation supported across all the evidence. If you have elevated triglycerides or existing cardiovascular disease, talk to your doctor about prescription icosapent ethyl — not over-the-counter fish oil, which has not demonstrated cardiovascular event reduction in clinical trials. If you do take an OTC supplement, buy one with IFOS 5-star or USP verification, and check the EPA/DHA amounts on the supplement facts panel.
Skip the flaxseed oil capsules for heart health. ALA conversion to EPA is 5-8%, which is not enough. Eat flaxseed and walnuts because they're good foods with fiber and other nutrients, not because they're meaningful EPA sources.